Brent Saunders, Allergan plc (AGN)’s insider Made a Purchase of 3,300 Shares; 13 Analysts Covering Johnson Controls International plc (JCI)

A calculated and well-grounded act was made by the Chairman – President and CEO of Allergan Plc, Mr. Brent Saunders, yesterday, when he bought 3,300 shares, totalling $503,349 U.S Dollars, based on a market price of $152.5 per every share. At present, he possess 180,931 shares or 0.05% of Allergan Plc’s market cap (share price times the number of shares outstanding).

Among 25 analysts covering Johnson Controls Inc. (NYSE:JCI), 13 have Buy rating, 1 Sell and 11 Hold. Therefore 52% are positive. Johnson Controls Inc. had 82 analyst reports since July 28, 2015 according to SRatingsIntel. Robert W. Baird reinitiated Johnson Controls International plc (NYSE:JCI) on Tuesday, October 18 with “Outperform” rating. The firm has “Hold” rating given on Wednesday, October 11 by RBC Capital Markets. The rating was downgraded by Goldman Sachs on Monday, March 13 to “Neutral”. Susquehanna maintained Johnson Controls International plc (NYSE:JCI) rating on Friday, February 2. Susquehanna has “Hold” rating and $42.0 target. The firm earned “Hold” rating on Friday, January 12 by Susquehanna. The stock of Johnson Controls International plc (NYSE:JCI) has “Outperform” rating given on Tuesday, August 23 by Credit Suisse. The stock has “Neutral” rating by Robert W. Baird on Friday, January 5. The stock has “Buy” rating by HSBC on Monday, April 3. The stock of Johnson Controls International plc (NYSE:JCI) earned “Buy” rating by Normua on Friday, October 2. The firm has “Hold” rating given on Tuesday, February 14 by Argus Research. See Johnson Controls International plc (NYSE:JCI) latest ratings:

15/02/2018 Broker: Barclays Capital Rating: Equal-Weight New Target: $41 Initiates Coverage On
02/02/2018 Broker: Susquehanna Rating: Hold New Target: $42.0 Maintain
31/01/2018 Broker: RBC Capital Markets Rating: Hold New Target: $37.0 Maintain
23/01/2018 Broker: UBS Rating: Buy Initiates Coverage On
18/01/2018 Broker: Cowen & Co Rating: Hold New Target: $42.0 Downgrade
12/01/2018 Broker: Susquehanna Rating: Hold New Target: $41.0 Maintain
03/01/2018 Broker: RBC Capital Markets Rating: Hold New Target: $39.0 Maintain
05/01/2018 Broker: Robert W. Baird Old Rating: Outperform New Rating: Neutral Old Target: $48 Downgrade
08/12/2017 Broker: Goldman Sachs Old Rating: Neutral New Rating: Sell Old Target: $44 Downgrade
15/11/2017 Broker: Susquehanna Old Rating: Positive New Rating: Neutral Old Target: $49 Downgrade

Johnson Controls International plc operates as a diversified technology and multi industrial firm worldwide. The company has market cap of $34.43 billion. The firm operates through Buildings and Power Solutions divisions. It has a 23.06 P/E ratio. It designs, produces, markets, and installs heating, ventilating, and air conditioning systems, building management systems, controls, and security and mechanical equipment.

The stock increased 0.30% or $0.11 during the last trading session, reaching $37.18. About 628,996 shares traded. Johnson Controls International plc (NYSE:JCI) has risen 13.24% since March 8, 2017 and is uptrending. It has underperformed by 3.46% the S&P500.

Investors sentiment increased to 2.25 in 2017 Q3. Its up 1.50, from 0.75 in 2017Q2. It is positive, as 5 investors sold Johnson Controls International plc shares while 3 reduced holdings. 1 funds opened positions while 5 raised stakes. 999,054 shares or 44.59% less from 1.80 million shares in 2017Q2 were reported. Alphamark Ltd Liability, a Kentucky-based fund reported 95 shares. Altfest L J And Inc has 0.12% invested in Johnson Controls International plc (NYSE:JCI) for 6,252 shares. 501 were reported by Amer Rech Mngmt. California-based Gemmer Asset Management Limited Liability Corporation has invested 0.01% in Johnson Controls International plc (NYSE:JCI). Schwartz Counsel invested in 1.74% or 689,554 shares. Cutler Capital Ltd Llc has invested 0.34% of its portfolio in Johnson Controls International plc (NYSE:JCI). Edge Wealth Mgmt Limited stated it has 0% in Johnson Controls International plc (NYSE:JCI). Cleararc Inc has 0.14% invested in Johnson Controls International plc (NYSE:JCI). Vantage Investment Lc holds 0.01% of its portfolio in Johnson Controls International plc (NYSE:JCI) for 765 shares. Farmers National Bank has invested 0.08% of its portfolio in Johnson Controls International plc (NYSE:JCI). Cullinan Assoc Inc invested in 111,400 shares or 0.35% of the stock. Cibc Ww Mkts Corporation has 0.05% invested in Johnson Controls International plc (NYSE:JCI).

The stock decreased 0.40% or $0.62 during the last trading session, reaching $152.6. About 461,450 shares traded. Allergan plc (NYSE:AGN) has declined 3.42% since March 8, 2017 and is downtrending. It has underperformed by 20.12% the S&P500.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. The company has market cap of $50.41 billion. It operates through US Specialized Therapeutics, US General Medicine, and International divisions. It currently has negative earnings. The firm offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease.